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Abstract 
There is an increasing interest to develop various lactic acid bacteria (LAB) species as mucosal delivery vehicles, for 
which the development of a variety of cloning and expression systems for these bacteria is of primary importance. 
This study reports the complete nucleotide sequence of the cryptic plasmid pRCEID7.6 derived from the chicken 
probiotic LAB strain Lactobacillus casei TISTR1341. Sequence analysis and comparison showed that pRCEID7.6 is 
composed of nine putative open reading frames. The replicon origin of pRCEID7.6 consisted of untranslated origin of 
replication and translated replication protein B sequences. This region was used to construct Escherichia coli/L. casei 
shuttle vectors carrying erythromycin and chloramphenicol resistance genes as selective markers. Segregation and 
structural stability of the vectors in L. casei was sufficient for most genetic applications. The feasibility of this vector 
for heterologous protein expression in L. casei was determined by cloning in pRCEID-LC7.6, the gene encoding the 
nucleocapsid protein (NP), from the influenza A virus under the control of the homologous promoter from the lactate 
dehydrogenase gene. L. casei carrying this recombinant plasmid was shown to successfully express the NP protein. 
Therefore, this shuttle vector can be used for further study in the development of mucosal delivery vehicles.
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Background
Lactobacillus casei is a member of the lactic acid bacteria 
(LAB) that can be found in various environments, includ-
ing that of animal and human intestines (Kandler and 
Weiss 1986). Besides generally recognized as safe (GRAS) 
status, many strains of LAB including a number of L. 
casei strains are also recognized as probiotics, defined 
as “live microorganisms that, when administered in ade-
quate amounts, confer a health benefit on the host” (Hill 
et  al. 2014). Some strains of L. casei have been demon-
strated to exert probiotic properties, such as anti-infec-
tive, anti-tumor, and immunomodulating activity (Kim 
et al. 2006; Ohashi et al. 1989).
There is now a growing trend in the development of 
LAB as mucosal vaccines, as well as vehicles for the deliv-
ery of therapeutic and prophylactic molecules. A major 
advantage of using LAB as mucosal delivery vehicles is 
their ability to be engineered to express both homolo-
gous and heterologous proteins. Many studies have suc-
cessfully used L. casei to express a variety of heterologous 
proteins of viral (Suebwongsa et al. 2013), bacterial (Liu 
et  al. 2014), and mammalian origin (Qiu et  al. 2013). 
One critical step to develop L. casei and other LAB as 
mucosal delivery vehicles is to construct the expression 
systems for these bacteria. Generally, most of the genetic 
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manipulations in the development process are preferred 
to be done in Escherichia coli than in Lactobacillus spe-
cies, thus E.coli/Lactobacillus shuttle vectors are the 
essential part of the process.
The construction of E. coli/Lactobacillus shuttle vec-
tors is usually based on replicons, a DNA region that nec-
essary for plasmid replication, derived from both E. coli 
and Lactobacillus species. The replicon of later species 
is derived from cryptic plasmid of Lactobacillus species. 
For the effective expression system for either homolo-
gous or heterologous proteins, the basic biological prop-
erties of plasmid vector, for example mode of replication, 
copy number, and stability, are key factors (Shareck et al. 
2004). Previously, the researchers had determined the 
complete nucleotide sequence from three of the four 
plasmids derived from L. casei TISTR 1341, a probiotic 
strain isolated from chickens obtained from the Thai-
land Institute of Scientific and Technological Research 
(TISTR). The replicons from the largest and the smallest 
plasmids, pRCEID13.9 and pRCEID2.9 respectively, have 
already been successfully used to construct E. coli/Lacto-
bacillus shuttle vectors (Panya et al. 2012).
In this study, the fourth plasmid of L. casei TISTR 1341, 
pRCEID7.6, was sequenced and its sequence analyzed. 
The replicon of this plasmid was then used to generate a 
new E. coli/Lactobacillus shuttle vector. The vector was 
successfully used for the expression of NP, a synthetic 
gene based on the nucleocapsid protein (NP) gene of the 
influenza A virus, in L. casei. Expression of this protein 
would allow its use as a mucosal delivery vehicle for oral 
immunization.
Methods
Bacterial strains and their growth conditions
Bacterial strains used in this study are listed in Table 1. 
Lactobacillus strains were cultured statically in de Man 
Rogosa Sharpe (MRS) medium (Difco, East Molesey, 
UK) at 37  °C. E. coli cells were grown in Luria–Bertani 
(LB) broth at 37 °C with vigorous shaking. When needed, 
antibiotics were added to the media as follows: for E. 
coli, ampicillin (100  µg/ml), chloramphenicol (10  µg/
ml); for L. casei, erythromycin (2.5  µg/ml), chloram-
phenicol (5  µg/ml), and tetracycline (10  µg/ml). White/
blue selection was done on LB agar supplemented with 
ampicillin, 20  mg/ml of 5-bromo-4chloro-3-indolyl-β-
d-galatopyonoside (X-Gal) and 0.4  M of isopropyl-β-d-
thiogalactopyranoside (IPTG) (Sigma-Aldrich, St. Louis, 
MO, USA).
DNA isolation and purification
Plasmids from E. coli were isolated the by an alkaline lysis 
method, as described by Sambrook and Russell (2001). 
Plasmids from LAB were isolated by the O’Sullivan and 
Klaenhammer method (O’Sullivan and Klaenhammer 
O’Sullivan and Klaenhammer 1993). Total genomic DNA 
of L. casei was extracted and purified from the mid-log 
Table 1 List of bacterial strains, plasmids, and oligonucleotide primers utilized in this study
Underlined nucleotides show introduced restriction enzyme sites, which are indicated in parenthesis
TISTR Thailand Institute of Scientific and Technological Research, ATCC American Type Culture Collection
Materials Relevant properties Source or reference
Bacteria
 Escherichia coli XL-1 Blue White/blue screening Stratagene, La Jolla, CA
 Lactobacillus casei TISTR1341 Source of pRCEID7.6 native plasmid TISTR
 Lactobacillus casei RCEID02 Plasmid-free L. casei TISTR1341-derivative Panya et al. (2012)
 Lactobacillus casei ATCC393 Plasmid-free stain ATCC
Plasmids
 pUC19E Apr, Emr, pUC19 carrying the Emr gene from pE194 at the SmaI site Leenhouts et al. (1991)
 pGEM-T easy Apr, M13ori, T-overhang cloning vector Promega, MD, USA
 pRCEID-LC2.9 Apr, Emr, E. coli/L. casei shuttle vector based on pRCEID2.9 Panya et al. (2012)
 pRCEID-LC13.9Tc Apr, Tcr, pRCEID-LC13.9 derivative, the Tcr gene was inserted at SacI site Panya et al. (2012)
 pNZ8048 Cmr, NcoI site used for translational fusions, standard vector Mierau and Kleerebezem (2005)
Oligonucleotides Sequence (5′–3′)
 p6.8F-1 gggtcagttttgccttatg This study
 P6.8R-1 ctggcaatgactttgcgga This study
 p6.8F attgcttggatcctctggcatgacaaac (BamHI) This study
 p6.8R ctttttggtatacggatccagtcgcta (KpnI) This study
 SpeI-ldh_F caaactagtagcttttagtcctcgtgaaaa (SpeI) Suebwongsa et al. (2013)
 pnisNdeI attacatatgaagctcgcgttatcggtc (NdeI) Suebwongsa et al. (2013)
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phase of bacterial cultures by using QIAamp DNA Mini 
Kit according to the instructions of the manufacturer 
(Qiagen, Hilden, Germany). Purified plasmids were 
verified by agarose gels electrophoresis, stained with 
ethidium bromide and visualized under UV light, and 
photographed.
General DNA manipulation
General DNA manipulations were performed as 
described by (Sambrook and Russell 2001). Restriction 
endonuclease and T4 ligase were obtained from Fermen-
tas (Fermentas, USA), Taq and Pfu polymerases were 
obtained from RBC (RBC, Taiwan). PCR amplicons and 
DNA fragments from agarose gels were purified using 
the Gel/PCR DNA Fragments Extraction Kit (RBC, Tai-
wan) as recommended by the manufacturer. Nucleotide 
sequences of the recombinant plasmids were verified by 
sequencing using a MegaBACE 1000 sequencer (BioDe-
sign Co. Ltd., Pathumthani, Thailand).
Plasmid sequencing and assembly
The contig2310 with a length of 6814  bp had been 
obtained as reported elsewhere (Panya et al. 2012). This 
sequence has been found to share high homology to sev-
eral plasmids from LAB and proved to be unrelated to all 
other plasmid sequences from L. casei TISTR 1341. The 
researchers assumed the contig could be a major part 
of a plasmid with the length of 7.6 kb observed by aga-
rose gel electrophoresis in L. casei TISTR 1341 (Panya 
et  al. 2012). Thus, DNA from the band corresponding 
to that plasmid was extracted from a gel, purified, and 
used as a template to amplify the remaining sequence 
with conventional PCR using the primers p6.8F-1 and 
p6.8R-1 (Table 1). The amplicon obtained was cloned into 
pGEM-T easy vector and sequenced by using the prim-
ers M13F(−40) and M13R(−40) (Table 1). The obtained 
sequence was assembled with that of the previous con-
tig2310 by using CLC Workbench 5.6 program.
Analysis of the plasmid nucleotide sequence
Nucleotide sequence similarity searches were performed 
using the BLAST program at the NCBI database (http://
www.ncbi.nlm.nih.gov/BLAST/). Open reading frames 
(ORFs), Direct (DR) and Inverse (IR) repeat sequences, 
restriction endonuclease sites, and plasmid maps were 
determined using Clone Manager 7.0 software. The 
putative promoter and ribosome binding site (RBS) 
sequences were searched for by comparing with the con-
sensus sequences (TTGACA for −35 box, TATAAT for 
−10 box, and AGGAGG for RBS). Protein structure and 
motives were searched for by using the Pfam search tool 
(http://pfam.sanger.ac.uk/).
Plasmid transfer
Plasmids were introduced into either E. coli or L. casei by 
electroporation. E. coli electroporation was performed 
using a Gene Pulser apparatus (Bio-Rad, Richmond, CA, 
USA) as described by Dower et al. (1988). Preparation of 
competent cells and electroporation of L. casei was per-
formed as previously described by (Chassy and Flickinger 
1987).
Construction of E. coli/L. casei shuttle vector
The cloning procedure to obtain the pRCEID7.6-derived 
shuttle vector is shown in Fig. 2. Initially, a DNA sequence 
containing the ori, and repB genes from pRCEID7.6 
was amplified by PCR using primers p6.8F and p6.8R 
(Table 1). The amplified segment was cloned into pGEM-
T Easy vector resulting in a pGEM:pRCEID7.6Rep. 
The pRCEID7.6 replicon was recovered from 
pGEM:pRCEID7.6Rep by double AatII/NdeI digestion 
and cloned into AatII/NdeI-digested pUC19E, a pUC19 
derivative contain E. coli replicon that does not repli-
cate in L. casei but contains an erythromycin resistance 
gene as selective marker (Leenhouts et  al. 1991), result-
ing in the construct pRCEID-LC7.6. To change the selec-
tive marker from erythromycin-resistant gene (EmR) to 
chloramphenicol-resistant gene (cat), the pRCEID-LC7.6 
was digested with SalI to remove the EmR gene and was 
self-ligated, giving rise to pRCEID-LC7.6ery-. The chlo-
ramphenicol resistant gene (cat) was obtained from 
pNZ8048 by double SalI/SpeI digestion and was inserted 
into SalI/SpeI-digested pRCEID-LC7.6ery-, resulted in 
pRCEID-LC7.6Cm.
Segregational and structural stability of the constructs
The segregational and structural stability of a pRCEID-
LC7.6 shuttle vector was studied in L. casei RCEID02, 
a plasmid-free derivative from L. casei TISTR 1341. 
Transformants with pRCEID-LC7.6 were grown in 
MRS broth without erythromycin for approximately 
200 generations. Every 20 generations, an aliquot of 
the culture was removed, diluted, and plated onto 
antibiotic-free MRS medium. One hundred colonies 
were selected and then replicated on MRS agar with 
and without erythromycin. For segregational stability, 
colonies grown on MRS agar with and without anti-
biotics were counted and calculated as follow: (NA/
NNA) × 100, where NA and NNA is number of colonies 
appearing on MRS plate with and without erythromy-
cin, respectively. For plasmid structural stability was 
checked by restriction analysis of plasmids isolated 
from colonies grown on MRS agar supplement with 
erythromycin at approximately 20, 40, 60, 80 and 100 
generation intervals.
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Determination of plasmid copy number
Real-time quantitative PCR was used to determine 
the relative copy number of pRCEID-LC7.6 in L. casei 
RCEID02 as described by (Lee et  al. 2006). The copy 
number of the constructs was calculated using the for-
mula Nrelative  =  (1  +  E)−ΔCT, where E is amplification 
efficiency of the target (EmR) and reference (greA) genes, 
and −ΔCT is the difference between the threshold cycle 
number of the reference gene and that of the target. DNA 
amplification and detection was performed in a Fast 
Real-Time PCR equipment (Applied Biosystems, Foster 
City, CA, USA) using SYBR® Green (Power SYBR® Green 
PCR Master Mix, Applied Biosystems).
Compatibility of the construct
The compatibility of pRCEID-LC7.6Cm with other vec-
tors was assayed in L. casei RCEID02. Competent cells of 
L. casei harboring pRCEID-LC7.Cm were electrotrans-
formed with pRCEID-LC2.9 and pRCEID-LC13.9Tc. 
Transformants were grown on MRS agar supplemented 
with appropriate antibiotics. The colonies on MRS agar 
were randomly selected for plasmid isolation. The plas-
mid profile was verified by agarose gel electrophoresis.
Construction of pRCEID‑LC7.6:LdhL:NP:TT
The DNA segment containing the promoter of the lac-
tate dehydrogenase (LdhL) gene, the synthetic gene 
encoding the NP protein of influenza A virus and a 
transcription terminator (TT) obtained from pNZ8048, 
was amplified from pLC13.9:LdhL:NP:TT (Suebwongsa 
et  al. 2013) using primers SpeI-ldh_F and pnisNdeI 
(Table  1). The amplicon was digested with SpeI/NdeI 
and inserted into pRCEID-LC7.6 digested with the 
same restriction endonuclease enzymes, resulting in 
pRCEID-LC7.6:LdhL:NP:TT.
Detection of NP by Western blotting analysis
The bacterial cell lysates obtained by sonication from 
overnight cultures of E. coli and L. casei RCEID02 trans-
formants containing pRCEID-LC7.6:LdhL:NP:TT were 
subjected to SDS-PAGE (12  % of SDS-PAGE, 100  V for 
2 h) and their proteins transferred from the gel to a nitro-
cellulose membrane (Bio-Rad, Hercules, California, USA) 
by using the Trans-Blot® SD Semi-Dry Electrophoretic 
Transfer Cell (Bio-Rad, Hercules, California, USA). The 
NP protein on the membrane was detected by a chemilu-
minescent detection system (CL-XPosure Film; Thermo 
Scientific, West Palm Beach, Florida, USA) using anti-
Avian Influenza A Nucleoprotein antibody (Abcam, 
Cambrideg, UK), HRP-conjugated anti-rabbit IgG anti-
body (Abcam, Cambrideg, UK), and SuperSignal West 
Pico Chemiluminescent Substrate (Thermo Scientific, 
West Palm Beach, Florida, USA).
Nucleotide sequence accession number
The complete nucleotide sequence of pRCEID7.6 was 
deposited in the GenBank database under accession 
number JN793951.
Results
Sequencing, sequence comparison and assemblage 
of pRCEID7.6
Initially, the contig2310 with a total length of 6814 
bases showed a nucleotide identity of 96 and 87  % of 
the segments embraced by the positions 696–3639 and 
5944–6814 respectively to sequences of plasmid pCD01 
(AY662330.1) from Lactobacillus paracasei NFBC338, 
strongly suggesting that the contig may be part of 
pRCEID7.6, the missing plasmid of L. casei TISTR 1341 
(Panya et al. 2012). To verify this possibility and to com-
plete the nucleotide plasmid sequence, primers in oppo-
site orientation were designed based on the sequence 
flanking both sides of the contig and used in PCR ampli-
fications using as a template plasmid pRCEID7.6 isolated 
from a gel. A single amplicon of 1 kb was obtained which 
was subsequently cloned in E. coli in the pGEM-T vector 
and double stranded sequenced. Finally, assemblage of 
the new sequence to that of contig2310 produced a total 
7604 bp which, after analysis, was considered to consti-
tute the whole molecule of pRCEID 7.6.
Sequence analysis of pRCEID7.6
The genetic organization of the plasmid pRCEID7.6 is 
depicted in Fig.  1. Nucleotide and deduced amino acid 
comparisons against the GenBank database predicted 
that pRCEID7.6 was composed of nine ORFs larger than 
50 amino acids. The products of these ORFs and the most 
homologous protein in databases to each of them are 
listed in Table 2.
The product of three ORFs, repB, ORF3, and ORF7, 
encoded putative proteins involved in plasmid replica-
tion. The repB gene encoded a protein of 259 amino acids 
with 100 % amino acid identity with the replication pro-
tein B (RepB) of plasmid pCD01 (YP_003329273.1) from 
L. paracasei. Upstream of the repB gene of pRCEID7.6, a 
putative origin of replication (ori) region was observed, 
including a DR of 10-bp (ATACTTCTAA) repeated 
two times, and a tandem DR of 22-bp (ATAGGTCAC-
CAAAAAGCACACG) repeated four times followed by 
a truncated repeat (ATAGGTCACCAAAAAG). This 
organization resembles the typical feature of the theta-
replicating plasmid family of pUCL287 (Kanatani et  al. 
1995). Downstream of the 22-bp DR, a putative promoter 
(TTGtgtn15TtaAAT) was found. In addition, a possible 
ribosome binding site (RBS) (GAGGTG) downstream 
of the promoter was observed 7  bp upstream from the 
start codon of repB (ATG). Therefore, based on sequence 
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similarity, pRCEID7.6 could be reasonably ascribed to 
the theta-mode of replication.
Surprisingly, the gene product of ORF3 and ORF7 
also showed homology to replication-associated pro-
teins. ORF3 encoded 179 amino acid that have a 100  % 
identity to whole replication protein of plasmid pCD01 
(YP_003329275.1) from L. paracasei NFBC338. Simi-
larly, the gene product of ORF7, a protein of 116 amino 
acids, showed 99  % (115 amino acid identity) sequence 
identity to a 116 amino acids of putative replication pro-
tein of plasmid pLR001 (YP_002221586.1) from L. para-
casei HN001. However, since the immediate upstream 
sequence of these two ORFs lack the typical features of 
ori region, such as those described for repB, they are 
considered to be non-functional for the replication of 
pRCEID7.6
ORF2 and ORF4 encoded protein with unknown 
function. ORF2 encoded 103 amino acid with 97  % 
similarity to hypothetical protein of plasmid pCD01p08 
(YP_003329274.1) from L. paracasei. ORF4 encoded a 
protein of 122 amino acids with 100  % similarity to an 
hypothetical protein of plasmid1 (YP_796451.1) from L. 
casei ATCC334. A conserved RBS (GGGAGA) was found 
at 7 bp upstream of the start codon (ATG) of ORF4. The 
gene product of ORF5 consisted of 216 amino acids with 
100 % homology to an hypothetical protein of plasmid1 
of L. casei ATCC334 (YP_796451). ORF8 and ORF9 were 
found to encode proteins responsible, most likely, for 
plasmid recombination and integration. ORF8 encoded 
a protein of 178 amino acid s with 96  % identity to 
transposases (ZP_04672204.1) from L. paracasei 8700:2. 
This protein is known as a member of transposase fam-
ily with DDE_Tnp domain (PF01609). Similarly, ORF9 
encoded a protein of 106 amino acids with 100 % identity 
to transposase (tnp4) (CAQ65752.1) from L. casei BL23 
and transposase AEA57601.1 from L. casei BD-II.
ORF6 encoded a peptide very similar to the partial part 
of C-terminal domain of a type IC specificity subunit 
protein with Methylase_S domain (pfam, PF01420). This 
domain is also known as a member of target recognition 
domain (TRD) involved in bacterial restriction-modifica-
tion system.
Construction and characterization of the E. coli/L. casei 
shuttle vectors
Figure  2 shows the cloning steps for constructing the 
pRCEID7.6-derived E. coli/L. casei shuttle vectors. 
From the sequence analysis, it was considered that the 
pRCEID7.6 replication region (including the ori sequence 
and repB) could consist in the DNA segment encompass-
ing the nucleotide positions from 135 to 1076. Primers 
were designed to amplify this region and the resulting 
amplicon was cloned in E. coli in pUC19E. As this vector 
carries an erythromycin resistance gene active in Gram-
positives, the construct pRCEIC-LC7.6 was then electro-
transformed into L. casei RCEID02 where it proved to 
drive plasmid replication.
For the vector to be compatible with the two previous 
vectors developed from other plasmids from the L. casei 
TISTR 1341 strain, the erythromycin resistance gene of 
construct pRCEID-LC7.6 was changed by a chloram-
phenicol resistance gene, giving rise to plasmid pRCEID-
LC7.6Cm (Fig.  2). It was found that pRCEID-LC7.6 
could compatibly replicate with both pRCEID-LC2.9 and 
pRCEID-LC13.9Tc in the same bacterial host (Fig. 3).
Structural and segregational analysis in L. casei 
RCEID02 indicated that the vector pRCEID-LC7.6 was 
maintained in 75 and 16 % of the cells after 100 and 200 
generations, respectively, in the absence of selective pres-
sure (without antibiotics) (Fig. 4). Additionally, structural 
changes of plasmid after 100 generations were never 
observed (Fig. 5). The relative copy number per chromo-
some equivalent of the constructs was found to be 12 
copies per chromosome in L. casei RCEID02.
Expression of a heterologous protein in L. casei RCEID02 
using pRCEID‑LC7.6
To determine whether pRCEID-LC 7.6 can be used 
for expression of heterologous proteins, the construct 
pRCEID-LC7.6:LdhL:NP:TT was developed. It is a 
pRCEID-LC7.6 derivative carrying an expression cas-
sette composed of the ldh gene promoter, a codon-
optimized, synthetic gene encoding the NP of influence 
Fig. 1 Physical and genetic map of the plasmid pRCEID7.6 (7604 bp) 
from L. casei TISTR1341. Arrows indicate the length and direction of 
the ORFs. Relevant unique restriction enzyme sites are indicated. The 
ori region of the plasmid is denoted by a solid box. DR direct repeats, 
IR inverted repeats
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A virus, and a transcription terminator derived by PCR 
from pLC13.9:LdhL:NP:TT (Suebwongsa et al. 2013) was 
introduced into E. coli XL-1 blue and L. casei RCEID02. 
Expression of the NP protein in both hosts was deter-
mined by Western blot analysis. As shown in the Fig. 6, 
a protein of the expected size of NP (56 kD), and identi-
cal to that of a cell lysate infected with the influenza virus 
H1N1 used as a control, was clearly revealed in transfor-
mants of the two species. In addition, the expression level 
of NP in L. casei RCEID02 after using the different plas-
mids, pRCEID-LC 7.6 and pRCEID-LC13.9 as backbone 
vector, was compared. It was found that that expression 
level of NP in L. casei RCEID02 was not difference as 
shown in Fig. 7.
Discussion
Lactobacillus casei is a member of LAB that has drawn 
a lot of attention as the candidate for the development 
of mucosal delivery vehicles (Wen et al. 2012). This bac-
terial species has been recognized as safe and certain 
strains possess probiotic properties conferring vari-
ous health benefits to the hosts (Dong et al. 2013). For 
example, L. casei strain Shirota was demonstrated to 
enhance NK cell activity by dairy intake (Takeda and 
Okumura 2007; Takeda et  al. 2006). It has been dem-
onstrated that oral administration of L. casei Shirota in 
humans can prevent and reduce the risk of the occur-
rence of bladder carcinoma (Aso et  al. 1995; Ohashi 
et al. 2002). Besides probiotic properties, L. casei has the 
most essential property for development as a mucosal 
delivery vehicle, the ability to be genetically engineered. 
For genetic engineering in L. casei and other LAB, plas-
mid replicons are generally required to develop the 
genetic tools for manipulation. The researchers’ previ-
ous study (Panya et  al. 2012) sequenced and analyzed 
three cryptic plasmids present in L. casei TISTR1341 
Table 2 Open reading frames (ORFs) identified in the 7604-bp plasmid pRCEID7.6 from L. casei TISTR1341
a ORFs are encoded on the complementary strand
Gene/ORF % GC content 5′ end position 3′ end position No. of aa. Known protein with the 
highest homology 
(microorganism)
% amino 
acid identity 
(length)
GenBank 
accession no.
repB 39 297 1076 259 Plasmid replication  
protein, RepB
100 (259) YP_003329273.1
Plasmid pCD01p07  
(L. paracasei subsp.  
paracasei)
ORF2 42 1461 1772 103 Hypothetical protein of  
plasmid pCD01p08  
(L. paracasei subsp.  
paracasei)
97 (100) YP_003329274.1
ORF3a 41 1609 2148 179 Putative replication  
protein of plasmid  
pCD01 (L. paracasei  
subsp. paracasei)
100 (179) YP_003329275.1
ORF4a 36 2316 2684 122 Hypothetical protein 
LSEI_A19 of plasmid1  
(L. casei ATCC334)
100 (122) YP_796451.1
ORF5a 39 2977 3627 216 Hypothetical protein of  
plasmid1 (L. casei)
100 (216) YP_005351865
ORF6a 38 3696 4886 396 C-terminus part of type  
IC specificity subunit  
protein (L. rhamnosus)
92 (180) ZP_04439481.1
ORF7 43 6027 6377 116 Plasmid replication  
protein of pLR001  
(L. rhamnosus HN001)
99 (115) YP_002221586.1
ORF8a 45 6701 7237 178 Transposase (L. paracasei  
subsp. paracasei 8700:2)
96 (165) ZP_04672204.1
ORF9a 45 7168 7488 106 Transposase tnp4  
(L. casei BL23)
100 (106) YP_002221607.1
Transposase  
(L. rhamnosus HN001)
100 (106) YP_002221607.1
Transposase  
(L. buchneri ATCC 11577)
100 (106) ZP_03943910.1
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and selected two replicons, one from pRCEID13.9 and 
the other from pRCEID2.9, to construct E.coli/Lacto-
bacillus shuttle vectors, pRCEID-LC13.9 and pRCEID-
LC2.9 respectively. Due to the high structural and 
segregational stability of pRCEID-LC13.9, this vector 
was successfully used for expressing the nucleocapsid 
protein of influenza A virus in L. casei RCEID02 (the 
plasmid-free derivative of L. casei TISTR1341) in the 
researchers’ subsequent study (Suebwongsa et al. 2013). 
In this present work, the pRCEID7.6 were completely 
sequenced and analyzed. The replicon of pRCEID7.6 
was identified and selected to construct a new shuttle 
Fig. 2 Construction of the shuttle vectors, pRCEID-LC7.6 and its derivatives, pRCEID-LC7.6ery-, and pRCEID-LC7.6Cm. amp, ery and cm = ampicillin, 
erythromycin, and chloramphenicol resistant genes respectively
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vector using pUC19E as backbone. The new vector, 
pRCEID-LC7.6, showed excellent structural stabil-
ity as there was no structural change after 100 genera-
tions. For segregation stability, though the stability was 
less than that of pRCEID13.9 and pRCEID-LC2.9, and 
it was sufficient (75 and 16  % after 100 and 200 gen-
erations, respectively) for protein expression and other 
genetic processes in this system. Though not thor-
oughly verified, replication in other strain of L. casei 
is expected as pRCEID-LC13.9 and 2.9 were shown to 
be able to replicate in different L. casei strains (Panya 
et al. 2012). In addition, as this vector can replicate with 
both pRCEID13.9 and pRCEID2.9 in a single cell, this 
allows the development of more robust, naturally com-
patible vectors. Finally, pRCEID-LC7.6 was used for the 
expression of NP of influenza A virus under the control 
of lactate dehydrogenase promoter in L. casei RCEID02. 
The successful expression of a heterologous protein in 
L. casei in this study allows further promising develop-
ment of this vector as a mucosal delivery vehicle in the 
near future.
Conclusion
The present study reported the completion of the plas-
mid complement of L. casei TISTR 1341, which consists 
in four plasmids, pCREID2.9, pRCEID3.2, pCREID7.6, 
and pRCEID13.9. As the replicons of all four plasmids 
are naturally compatible, the development vectors based 
on these plasmid replicons would provide high flexibil-
ity for cloning and expression of homologous and het-
erologous proteins in L. casei and other LAB species. 
The suitability of the new cloning vector pRCEID-LC7.6 
was demonstrated by cloning and expressing the nucle-
ocapsid protein-encoding gene from the influenza A 
virus. Expression of this protein would allow its use as a 
mucosal delivery vehicle for oral immunization.
Fig. 3 Ethidium bromide staining agarose gel of plasmid profile 
of L. casei RCEID02 harboring pRCEID-LC7.6Cm (5.1 kb), pRCEID-
LC2.9 (5.3 kb), and pRCEID-LC13.9Tc (7.1 kb). Lane 1 plasmid profile 
of L. casei RCEID02 harboring pRCEID-LC7.6Cm, pRCEID-LC2.9, and 
pRCEID-LC13.9Tc. Lane M Super coiled DNA ladder (Invitrogen, USA). 
On the left, sizes in base pairs of the different molecules of the ladder. 
The electrophoresis reaction was carried out by using 0.7 % agarose 
gel electrophoresis in ×1 TAE buffer at 50 voltages for 3 h
Fig. 4 Segregational stability of the shuttle vectors pRCEID-LC7.6 in L. 
casei RCEID02. L. casei RCEID02 harboring these plasmids was culture 
in the absence of selective pressure, plated on the same condition, 
and assayed for plasmid maintenance by replica-plating onto erythro-
mycin-containing MRS medium at approximately 20, 40, 60, 80, 100, 
120, 140, 160, 180 and 200 generation intervals. Em erythromycin
5000 
3000 
2000 
1650 
 3,148 bps 
 1,935 bps 
Fig. 5 Ethidium bromide staining gel of HindIII-digested shuttle 
vector pRCEID-LC7.6. Lane 2–6 HindIII-digested pRCEID-LC7.6 derived 
from the generation time of 20, 40, 60, 80 and 100, respectively. Lane 
1 the original vector pRCEID-LC7.9 digested with HindIII. Lane M 
MassRuler™ Express Reverse DNA ladder
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